BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Skajaa GO, Mathiesen ER, Iyore E, Beck-Nielsen H, Jimenez-Solem E, Damm P. Poor pregnancy outcome after octreotide treatment during pregnancy for familial hyperinsulinemic hypoglycemia: a case report. BMC Res Notes 2014;7:804. [PMID: 25404386 DOI: 10.1186/1756-0500-7-804] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Meoni G, Giommoni E, Petreni P, Pillozzi S, Mazzoni F, Pellegrini E, Brugia M, Lunghi A, Muto A, Antonuzzo L. Somatostatin analogs in pregnant patients with neuroendocrine tumor. Anti-Cancer Drugs 2020;31:1096-8. [DOI: 10.1097/cad.0000000000000967] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Haris B, Saraswathi S, Hussain K. Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia. Ther Adv Endocrinol Metab 2020;11:2042018820965068. [PMID: 33329885 DOI: 10.1177/2042018820965068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Kevat D, Chen M, Wyld D, Fagermo N, Lust K. A case of pulmonary carcinoid in pregnancy and review of carcinoid tumours in pregnancy. Obstet Med 2017;10:142-9. [PMID: 29051783 DOI: 10.1177/1753495X16687700] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Geilswijk M, Andersen LL, Frost M, Brusgaard K, Beck-Nielsen H, Frederiksen AL, Jensen DM. Octreotide therapy and restricted fetal growth: pregnancy in familial hyperinsulinemic hypoglycemia. Endocrinol Diabetes Metab Case Rep 2017;2017:16-0126. [PMID: 28458896 DOI: 10.1530/EDM-16-0126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]